|
atrial fibrillation |
21 |
|
myocardial infarction |
14 |
|
secondary prevention |
12 |
|
chinese |
11 |
|
time in therapeutic range |
11 |
|
25-hydroxyvitamin d |
10 |
|
gastrointestinal haemorrhage |
10 |
|
genetic polymorphism |
10 |
|
vitamin d-binding protein |
10 |
|
cha2ds2-vasc |
8 |
|
chads2 |
8 |
|
coronary artery disease |
8 |
|
trs 2°p |
8 |
|
venous thromboembolism |
8 |
|
intracranial hemorrhages |
7 |
|
cardiovascular event |
6 |
|
dabigatran |
6 |
|
elderly |
6 |
|
high sensitive troponin level |
6 |
|
non-st elevated myocardial infarction |
6 |
|
screening |
6 |
|
st segment elevation myocardial infarction |
6 |
|
statin intolerance |
6 |
|
timi grading system |
6 |
|
acute coronary syndrome |
5 |
|
brugada syndrome |
5 |
|
chronic kidney disease |
5 |
|
genetic analysis |
5 |
|
heart failure |
5 |
|
international normalized ratio |
5 |
|
intracranial hemorrhage |
5 |
|
ischaemic stroke |
5 |
|
ischemic stroke |
5 |
|
long qt syndrome |
5 |
|
mexiletine |
5 |
|
monomorphic ventricular tachycardia |
5 |
|
mortality |
5 |
|
non-vitamin k antagonist oral anticoagulants |
5 |
|
non-vitamin k oral anticoagulants |
5 |
|
percutaneous coronary intervention |
5 |
|
peritoneal dialysis |
5 |
|
polymorphic ventricular tachycardia |
5 |
|
quinidine |
5 |
|
ventricular fibrillation |
5 |
|
warfarin |
5 |
|
2-hour ecg |
4 |
|
annonaceae |
4 |
|
anticholesteremic agents |
4 |
|
asian |
4 |
|
bare-metal stents |
4 |
|
bradycardia |
4 |
|
cardiovascular diseases/prevention and control |
4 |
|
cholesterol, ldl |
4 |
|
clinical characteristics |
4 |
|
deep vein thrombosis |
4 |
|
drug-eluting stents |
4 |
|
geriatric patients |
4 |
|
heart rate |
4 |
|
hypercholesterolemia |
4 |
|
methamphetamine |
4 |
|
mitrephora monocarpa |
4 |
|
new species |
4 |
|
outcomes |
4 |
|
pregnancy |
4 |
|
pulmonary embolism |
4 |
|
pulmonary hypertension |
4 |
|
sudden arrhythmic death |
4 |
|
symptoms |
4 |
|
thailand |
4 |
|
treatment outcome |
4 |
|
trend |
4 |
|
ventricular tachycardia, ventricular fibrillation |
4 |
|
apixaban |
3 |
|
device related thrombus |
3 |
|
ehealth/telemedicine/mobile health |
3 |
|
left atrial appendage occlusion |
3 |
|
microlife |
3 |
|
mobile app |
3 |
|
photoplethysmography |
3 |
|
premature ventricular beats |
3 |
|
smartphone |
3 |
|
stroke |
3 |
|
biventricular pacing/defibrillation |
2 |
|
cardiovascular outcomes |
2 |
|
carotid intima-media thickness |
2 |
|
chronic total occlusion |
2 |
|
clinical |
2 |
|
common carotid artery |
2 |
|
implantable devices |
2 |
|
mitral regurgitation |
2 |
|
plaque composition |
2 |
|
statin |
2 |
|
stents |
2 |
|
virtual histology |
2 |
|
aortic regurgitation |
1 |
|
aortic stenosis |
1 |
|
apposition |
1 |
|
atherosclerotic plaque |
1 |
|
balloon aortic valvuloplasty |
1 |
|
balloon predilatation |
1 |
|
bifurcation |
1 |
|
bifurcations |
1 |
|
corevalve |
1 |
|
coronary artery |
1 |
|
coronary lesion assessment |
1 |
|
coronary plaque |
1 |
|
degenerative mitral regurgitation |
1 |
|
diagnostic imaging |
1 |
|
direct aortic approach |
1 |
|
echocardiography |
1 |
|
failing bioprosthesis |
1 |
|
frequency domain optical coherence tomography |
1 |
|
functional mitral regurgitation |
1 |
|
guide extension |
1 |
|
guideliner |
1 |
|
horizontal aortic root |
1 |
|
intimal hyperplasia |
1 |
|
intravascular imaging |
1 |
|
kissing |
1 |
|
lesion assessment |
1 |
|
malapposition |
1 |
|
mitraclip |
1 |
|
mitraclip® |
1 |
|
mitral valve area |
1 |
|
mitral valve repair |
1 |
|
neointima |
1 |
|
optical coherence tomography |
1 |
|
percutaneous coronary interventions |
1 |
|
percutaneous mitral valve repair |
1 |
|
post-dilation |
1 |
|
quality of life |
1 |
|
saphenous vein graft |
1 |
|
stent |
1 |
|
stent delivery |
1 |
|
stent optimization |
1 |
|
transcatheter aortic valve implantation |
1 |
|
two-stent strategies |
1 |
